Congressman Mike Fitzpatrick Questions FDA about Essure Reporting Changes
There have been some unique and inexplicable changes in adverse event reporting regarding Bayer’s “permanent” birth control device, Essure. The changes began July 17, 2015 after the agency announced its review of Essure’s safety and efficacy. In a recent letter, Congressman Mike Fitzpatrick questions FDA about Essure reporting changes.